Status:
COMPLETED
Ovarian Cancer Patient-Centered Decision Aid
Lead Sponsor:
University of California, Irvine
Collaborating Sponsors:
Patient-Centered Outcomes Research Institute
Conditions:
Stage III Ovarian Cancer
Eligibility:
FEMALE
21+ years
Phase:
NA
Brief Summary
The objective of this study is to develop and test a new decision aid -named Patient Centered Outcome Aid (PCOA)-that will allow patients to assimilate information and identify trade-offs about the im...
Detailed Description
Ovarian cancer is typically diagnosed at an advanced stage and carries the highest fatality-to-case ratio of all gynecologic malignancies diagnosed in the United States. Arguably the most effective tr...
Eligibility Criteria
Inclusion
- RCT participants will include stage III optimally debulked advanced ovarian cancer patients from urban and rural regions of the country, who will be randomized to either our patient-centered decision-aid or the usual care control arm
Exclusion
- By the nature of the neoplasm under study, gender specific (ovarian cancer), only female patients will be included
- Patient enrollment will include women from all English speaking ethnic groups
- \> the age of 21
- All minority ovarian cancer survivors will be eligible
- Women under age 21 will not be included in this study because it is not common to be diagnosed with advanced epithelial ovarian cancer in females under age 21
Key Trial Info
Start Date :
December 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2016
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT02259699
Start Date
December 1 2014
End Date
December 31 2016
Last Update
June 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California
Irvine, California, United States, 92697